⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab) and Xeloda (Capecitabine) in Patients With HER2-Positive Breast Cancer

Official Title: A Single Arm Open-label, Phase II Study of Bevacizumab in Combination With Trastuzumab and Capecitabine as First-line Treatment of Patients With HER2-positive Locally Recurrent or Metastatic Breast Cancer

Study ID: NCT00811135

Conditions

Breast Cancer

Study Description

Brief Summary: This single arm study will assess the efficacy and safety of Avastin in combination with Herceptin and Xeloda as first-line treatment of patients with HER2-positive locally recurrent or metastatic breast cancer. Patients will receive 3-weekly treatment cycles of Herceptin (8mg/kg iv on day 1 of first cycle, followed by 6mg/kg iv maintenance dose on day 1 of subsequent cycles), Xeloda (1000mg/m2 bid po on days 1-14 of each treatment cycle) and Avastin (15mg/kg on day 2 of first treatment cycle,and on day 1 of each subsequent cycle).The anticipated time on study treatment is until disease progression, and the target sample size is \<100 individuals.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

, Herlev, , Denmark

, Vejle, , Denmark

, Aix En Provence, , France

, Beziers, , France

, Creteil, , France

, Dechy, , France

, Lormont, , France

, Marseille, , France

, Narbonne, , France

, Paris, , France

, Paris, , France

, Paris, , France

, Paris, , France

, Rodez, , France

, Saint Jean, , France

, Saint Quentin, , France

, Toulouse, , France

, Moscow, , Russian Federation

, Moscow, , Russian Federation

, Saint-Petersburg, , Russian Federation

, Bratislava, , Slovakia

, Barakaldo, Vizcaya, Spain

, Barcelona, , Spain

, Madrid, , Spain

, Madrid, , Spain

, Malaga, , Spain

, Pontevedra, , Spain

, Salamanca, , Spain

, Sevilla, , Spain

, Valencia, , Spain

, Valencia, , Spain

, Eskilstuna, , Sweden

, Sundsvall, , Sweden

, Uppsala, , Sweden

, Vaxjo, , Sweden

Contact Details

Name: Clinical Trials

Affiliation: Hoffmann-La Roche

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: